Polycistronic expression of antibodies

Details for Australian Patent Application No. 2002364956 (hide)

Owner Biogen Idec Inc.

Inventors Barnett, Richard; Reff, Mitchell

Agent Davies Collison Cave

Pub. Number AU-B-2002364956

PCT Number PCT/US02/36856

PCT Pub. Number WO2003/048306

Priority 60/400,687 05.08.02 US; 60/331,481 16.11.01 US

Filing date 18 November 2002

Wipo publication date 17 June 2003

Acceptance publication date 11 September 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/400,687 05.08.02 US; 60/331,481 16.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002364956

11 November 2004 Assignment before Grant

  IDEC Pharmaceuticals Corporation The application has been assigned to Biogen Idec Inc. 2003

11 September 2008 Application Accepted

  Published as AU-B-2002364956

5 February 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Dec 2008. Address for service in Australia - Davies Collison Cave Level 3 303 Coronation Drive Milton Business Centre QLD 4064

28 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Dec 2008

28 May 2009 Standard Patent Sealed

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364957-COATING PROCESS AND COMPOSITION FOR SAME

2002364955-STABLE, NON-HAZARDOUS INDICIA FOR BIOCIDAL IRRADIATION OF A PACKAGE